Clinical Trials

Our on-going research studies provide an opportunity to have your child, your adolescent, or yourself thoroughly screened for ADHD at no cost to you. Screening procedures will vary depending upon the type of study being conducted. If you meet diagnostic criteria for ADHD and inclusion criteria for one or more studies, you may be eligible to receive medication for the treatment of ADHD at no cost to you.

Imaging Stimulant and Non-Stimulant Treatments for ADHD: A Network Based Approach

Our recent work on the study Methylphenidate and Atomoxetine in ADHD: fMRI Measures of Mechanisms and Response produced exciting findings, offering a window into the common and unique neurophysiological mechanisms of response to stimulant and non-stimulant treatments. To enhance the interpretation and clinical utility of these results, we are conducting an in-depth investigation of the impact of the two treatments on relevant neural networks, and evaluating whether improvement is achieved via normalization or other adaptive changes in brain function. As participants in the study: Imaging Stimulant and Non-Stimulant Treatments for ADHD: A Network Based Approach, healthy youth and youth with ADHD will participate in fMRI brain scanning while performing neuropsychological tasks. Only youth with ADHD will be randomized to one of the medication treatment groups. Youth receiving medication will be carefully monitored during weekly visits with our study physicians during the 6-8 week duration of participation.

Location: Mount Sinai Health System, New York, NY
Sponsor: NIH

GCO# 11-0161 IRB approved 12-7-2012 to 4-30-2016

Beth Krone, PhD or Erica Pazmino, MA
Tel: 212-241-8012 or 212-241-5411
E-mail: or

Neurobiological Basis of Response to Vayarin® in Adults with ADHD: an fMRI Study of Brain Activation Pre and Post Treatment

Our prior research suggests that effective non-stimulant treatments for ADHD act through key prefrontal regions that subserve inhibitory and executive functions, although different medications may achieve these effects via distinct mechanisms. The objective of this research is to use functional magnetic resonance imaging (fMRI) with a face go/no-go task to test the prefrontal mechanism of action of the medical food Vayarin. Participants are not treated at the Icahn School of Medicine, but instead will be recruited from trials of Vayarin that are enrolling and treating participants at New York University and the Medical Research Network.

Location: Mount Sinai Health System, New York, NY

Sponsor: Enzymotec

GCO# 15-0399 IRB approved 3-24-2015 to 3-23-2016

Erica Pazmino, MA
Tel: (212) 241-5411

Contact Us

Center of Excellence for ADHD and Related Disorders
Icahn School of Medicine
Department of Psychiatry
One Gustave L. Levy Place
Box 1230
New York, NY 10029

For more information about research programs, 
please contact: 212-241-8012 or email

For more information about group therapy, 
please contact 212-241-5420 or email

For information about individual therapy or parenting work, 
please call 212-241-3843 or email

For more information about neuropsychological or psychoeducational assessment, 
please call 212-241-4423 or email

For more information about medication management, 
please call 212-659-8705 or email